1. Home
  2. ASMB vs ALTO Comparison

ASMB vs ALTO Comparison

Compare ASMB & ALTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • ALTO
  • Stock Information
  • Founded
  • ASMB 2005
  • ALTO 2003
  • Country
  • ASMB United States
  • ALTO United States
  • Employees
  • ASMB N/A
  • ALTO N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • ALTO Major Chemicals
  • Sector
  • ASMB Health Care
  • ALTO Industrials
  • Exchange
  • ASMB Nasdaq
  • ALTO Nasdaq
  • Market Cap
  • ASMB 92.1M
  • ALTO 120.3M
  • IPO Year
  • ASMB 2010
  • ALTO N/A
  • Fundamental
  • Price
  • ASMB $13.61
  • ALTO $1.57
  • Analyst Decision
  • ASMB Buy
  • ALTO Strong Buy
  • Analyst Count
  • ASMB 2
  • ALTO 3
  • Target Price
  • ASMB $35.00
  • ALTO $5.00
  • AVG Volume (30 Days)
  • ASMB 25.5K
  • ALTO 637.3K
  • Earning Date
  • ASMB 03-27-2025
  • ALTO 03-10-2025
  • Dividend Yield
  • ASMB N/A
  • ALTO N/A
  • EPS Growth
  • ASMB N/A
  • ALTO N/A
  • EPS
  • ASMB N/A
  • ALTO N/A
  • Revenue
  • ASMB $28,326,000.00
  • ALTO $1,002,536,000.00
  • Revenue This Year
  • ASMB $282.16
  • ALTO N/A
  • Revenue Next Year
  • ASMB N/A
  • ALTO $7.36
  • P/E Ratio
  • ASMB N/A
  • ALTO N/A
  • Revenue Growth
  • ASMB N/A
  • ALTO N/A
  • 52 Week Low
  • ASMB $9.84
  • ALTO $1.18
  • 52 Week High
  • ASMB $19.93
  • ALTO $2.40
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 39.96
  • ALTO 44.51
  • Support Level
  • ASMB $13.76
  • ALTO $1.56
  • Resistance Level
  • ASMB $14.67
  • ALTO $1.69
  • Average True Range (ATR)
  • ASMB 0.72
  • ALTO 0.09
  • MACD
  • ASMB -0.09
  • ALTO -0.02
  • Stochastic Oscillator
  • ASMB 2.03
  • ALTO 7.74

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About ALTO Alto Ingredients Inc.

Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include major food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Other production. The Marketing and distribution segment participates in marketing and merchant trading for alcohols and essential ingredients; Pekin Campus produces and sells products produced at the company's Pekin, Illinois, campus, and about half of the firm's revenue flows from this segment. Other production makes and sells from the company's other production facilities.

Share on Social Networks: